Merge Healthcare Incorporated (NASDAQ: MRGE), a leading provider of clinical systems and innovations that seek to transform healthcare, today announced that Merge Cardio™ has been named Best in KLAS for the cardiology software category within the “2013 Best in KLAS: Software & Services” report. In addition, Merge Hemo™ has been named the Category Leader in Cardiology Hemodynamics for the third successive year.
"We’re excited that not only has Merge Hemo retained its number one status as Category Leader for the third straight year, but Merge Cardio has received the Best in KLAS top honor this year, as well. We believe that both of these designations speak to our ongoing diligence in developing superior clinical solutions to meet our client’s needs,” said Justin Dearborn, CEO of Merge Healthcare. "What’s more, we’re honored to be the first vendor to receive top recognition from KLAS for both cardiology categories, and feel that this solidifies Merge’s leadership status in the CVIS market.”
Combined, Merge Hemo and Merge Cardio provide a seamless solution for advanced reporting and enhanced workflow. Currently running in over 500 cardiac cath labs in some of the country’s largest health systems, Merge Hemo captures real-time data and documents procedural events to enable efficient workflow. Merge Cardio, implemented in over 200 organizations, is a web-enabled enterprise-level image and information system that provides a single point of entry to the patient’s complete cardio record spanning all cardiac modalities.
KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers to be heard and counted. Working with thousands of healthcare professionals and clinicians, KLAS gathers data on software, services, medical equipment, and infrastructure systems to deliver timely reports, trends, and statistical overviews. The research directly represents the provider voice and acts as a catalyst for improving vendor performance. Follow KLAS on Twitter at www.twitter.com/KLASresearch.
Merge is a leading provider of innovative enterprise imaging, interoperability and clinical systems that seek to advance healthcare. Merge’s enterprise and cloud-based technologies for image intensive specialties provide access to any image, anywhere, any time. Merge also provides clinical trials software with end-to-end study support in a single platform and other intelligent health data and analytics solutions. With solutions that have been used by providers for more than 25 years, Merge is helping to reduce costs, improve efficiencies and enhance the quality of healthcare worldwide. For more information, visit merge.com and follow us @MergeHealthcare.
Cautionary Notice Regarding Forward-Looking Statements
The matters discussed in this press release may include forward-looking statements, which could involve a number of risks and uncertainties including the outcome of the internal investigation and the remedial actions involving the former employee. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, such forward-looking statements. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements.